| Dr Sandhya Iyer, MD | |
|
1201 Summit Ave, Fort Worth, TX 76102 | |
| (817) 332-2020 | |
| (817) 332-4797 |
| Full Name | Dr Sandhya Iyer |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 1201 Summit Ave, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285708073 | NPI | - | NPPES |
| 00A998750 | Other | CA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | N0124 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmic Partners , Pa | 4587578364 | 16 |
News Archive
New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on.
According to the Office of National Drug Control Policy, prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second only to marijuana use. In the face of this growing problem, Pisgah Labs, Inc. has just filed its eighth patent application on a technology that promises to curb prescription drug abuse.
Chronic kidney disease can develop in response to a variety of insults and is characterized by progressive renal fibrosis and atrophy of kidney tubule. Therapeutic options are limited and the disease is often not detected until later stages.
New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on.
According to the Office of National Drug Control Policy, prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second only to marijuana use. In the face of this growing problem, Pisgah Labs, Inc. has just filed its eighth patent application on a technology that promises to curb prescription drug abuse.
Chronic kidney disease can develop in response to a variety of insults and is characterized by progressive renal fibrosis and atrophy of kidney tubule. Therapeutic options are limited and the disease is often not detected until later stages.
New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
| Entity Name | Ophthalmic Partners , Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356474050 PECOS PAC ID: 4587578364 Enrollment ID: O20031117000188 |
News Archive
New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on.
According to the Office of National Drug Control Policy, prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second only to marijuana use. In the face of this growing problem, Pisgah Labs, Inc. has just filed its eighth patent application on a technology that promises to curb prescription drug abuse.
Chronic kidney disease can develop in response to a variety of insults and is characterized by progressive renal fibrosis and atrophy of kidney tubule. Therapeutic options are limited and the disease is often not detected until later stages.
New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandhya Iyer, MD 1201 Summit Ave, Fort Worth, TX 76102-4413 Ph: (178) 332-2020 | Dr Sandhya Iyer, MD 1201 Summit Ave, Fort Worth, TX 76102 Ph: (817) 332-2020 |
News Archive
New data shows that healthcare and personal costs to support survivors of stroke remains high 10 years on.
According to the Office of National Drug Control Policy, prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second only to marijuana use. In the face of this growing problem, Pisgah Labs, Inc. has just filed its eighth patent application on a technology that promises to curb prescription drug abuse.
Chronic kidney disease can develop in response to a variety of insults and is characterized by progressive renal fibrosis and atrophy of kidney tubule. Therapeutic options are limited and the disease is often not detected until later stages.
New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).
› Verified 3 days ago
Dr. David Truong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3900 N Tarrant Pkwy Ste 104, Fort Worth, TX 76244 Phone: 714-782-8401 | |
Dr. Taylor Boyd Strange, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9429 N Beach St, Fort Worth, TX 76244 Phone: 817-442-2020 Fax: 682-499-3856 | |
Daniel Edward Bruhl, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020 Fax: 817-332-4797 | |
Randy Joe Montgomery, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4825 Camp Bowie Blvd, Fort Worth, TX 76107 Phone: 817-336-2010 Fax: 817-377-0074 | |
Harry Rosenthal Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4932 Overton Ridge Blvd, Fort Worth, TX 76132 Phone: 817-423-3937 Fax: 817-423-3943 | |
George David Hendricks Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020 Fax: 817-332-4797 | |
Dwayne Lee Roberts, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1201 Summit Ave, Fort Worth, TX 76102 Phone: 817-332-2020 Fax: 817-332-4797 |